Chagas' disease (CD) is a significant public health concern in South America.
Chronic cardiomyopathy is the most prevalent clinical manifestation of CD, affecting approximately 30% of patients.
Chagasic cardiomyopathy presents with heart failure, arrhythmias, and thromboembolic events, typically 10-40 years post-infection.
Purpose:
To review the relationship between Chagasic cardiomyopathy and ischemic stroke.
To identify key predictors of ischemic stroke in patients with Chagas' disease.
To emphasize the importance of considering Chagasic cardiomyopathy in stroke differential diagnoses.
Summary:
Significant predictors for ischemic stroke in Chagasic patients include apical aneurysm (37% prevalence), cardiac insufficiency, and cardiac arrhythmia.
In at least 40% of cases, Chagas' disease diagnosis is established only after a stroke event.
Chagasic cardiomyopathy is a potential source of cardioembolic stroke and should be considered in stroke etiology evaluations.
Impact:
Highlights the critical link between Chagas' disease and stroke, particularly cardioembolic events.
Informs clinicians to include Chagasic cardiomyopathy in the differential diagnosis for stroke patients, especially in endemic regions.
Underscores the need for early recognition and management of Chagas' disease to prevent stroke complications.